Skip to main content
Premium Trial:

Request an Annual Quote

Women at the Top?

Women are underrepresented at the tops of science, technology, engineering, and mathematics firms in the UK, The Guardian reports. A study by the Royal Society of Edinburgh finds that the boards of science and engineering companies have female-to-male ratios as low as one woman per 75 men. Further, the report, called Tapping All Our Talents, notes that many STEM professional societies also have low numbers of female fellows — 4.9 percent of Royal Society of Chemistry fellows are female, The Guardian says.

The report, which was presented to members of Parliament on the business select committee, also says that of people who have a controlling stake or own a STEM company 8 percent are women, as compared to 41 percent for non-STEM firms. "I was aware there was a lower level in science and engineering, but I didn't realize it was quite so low," says Adrian Bailey, a Labour MP and chair of the committee.

The Guardian adds that the UK and professional organizations have taken steps to improve the representation of women in the science sector, but that more may need to be done.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.